Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 23,128 shares at $90.54 ($2.1M) on 2012-02-01, disclosed to the SEC on 2012-02-02.
Scheduled sale ($2.1M) by SVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.07 | 5,628 | $507K | 24.3% |
| 2 | $90.07 | 8,061 | $726K | 34.8% |
| 3 | $90.54 | 8,539 | $773K | 37.0% |
| 4 | $91.04 | 900 | $82K | 3.9% |
| Total | $90.28 avg | 23,128 | $2.1M | 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-11-19 | $9.1M | — | Filing → |